GlassScriptPhysician profile
Shawn M Magee
NPI 1831138460
$644.90
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $125 · 2022: $91.53 · 2023: $32.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $91.53 | 2022 | |
| Glaxosmithkline, LLC. | $81.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $54.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $46.04 | 2019-2020 | |
| Philips North America LLC | $44.27 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.77 | 2019 | |
| Mylan Specialty L.P. | $35.90 | 2019 | |
| 3b Medical, INC. | $32.87 | 2023 | Luna |
| Regeneron Healthcare Solutions, INC. | $30.77 | 2019-2020 | |
| Shire North American Group INC | $22.85 | 2019 | |
| Novo Nordisk INC | $20.10 | 2019 | |
| Harmony Biosciences LLC | $17.54 | 2020 | |
| Insmed, INC. | $17.23 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.17 | 2020 | |
| Smith+Nephew, INC. | $14.96 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $14.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.98 | 2020 | |
| Amgen INC. | $12.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.18 | 2019 | |
| Merck Sharp & Dohme LLC | $10.97 | 2019 | |
| Electromed, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.